REVIEW ON HOSPITAL FORMULARY: AN OVERVIEW

Prashanthi Evangelin M; Sahithi Pamidimalla; Srilalitha Chappidi; Bhargav Bachina; Shiny Bolledu; Rajeev Kumar T; Balaji R

doi:10.38022/ajhp.v6i1.131

M.Prashanthi Evangelin Vice Principal, Professor, Department of Pharmaceutical Chemistry, SIMS College Of Pharmacy, Guntur, Andhara Pradesh-522001.
prashanthievangelin89@gmail.com
Pamidimalla Sahithi Students, SIMS College of Pharmacy, Guntur, Andhara Pradesh.
Chappidi Srilalitha Students, SIMS College of Pharmacy, Guntur, Andhara Pradesh.
Bachina Bhargav Students, SIMS College of Pharmacy, Guntur, Andhara Pradesh.
Bolledu Shiny Students, SIMS College of Pharmacy, Guntur, Andhara Pradesh.
T.Rajeev Kumar Associate Professor, Department of Pharmaceutical Chemistry, SIMS College of Pharmacy
R Balaji Department of Pharmaceutics, SIMS College of Pharmacy

DOI https://doi.org/10.38022/ajhp.v6i1.131

Abstract

A hospital formulary represents a comprehensive and curated list of pharmaceutical preparations that have been specifically approved for administration within a healthcare facility. This systematic compilation functions as an indispensable instrument for maintaining medication safety standards, ensuring clinical efficacy in treatment protocols, and managing pharmaceutical expenditures responsibly. The development and maintenance of formularies falls under the purview of specialized committees-typically the Pharmacy and Therapeutics (P&T) Committee-which conducts rigorous evaluation of medicines across multiple parameters: therapeutic effectiveness, adverse effect profiles, manufacturing standards, and fiscal implications. The standardization of therapeutic agents through formulary implementation substantially diminishes the incidence of medication administration errors, promotes evidence-based prescribing methodologies, and ultimately enhances the quality of clinical outcomes for patients. Additionally, formularies serve as authoritative references for clinical decision-making, offering detailed information regarding therapeutic indications, appropriate dosage regimens, contraindications, and suitable pharmacological alternatives. The hospital formulary thus constitutes a cornerstone of institutional pharmaceutical governance, facilitating optimized medication regimens, fiscal prudence in resource allocation, and elevated standards of patient safety protocols.

Keywords: Hospital Formulary, Pharmaceutical Management, Clinical Governance, Drug Selection, Cost Control

Downloads

Download data is not yet available.

References

1. Summers KH, Steinbach SL. Formularies: The role of pharmacy-and-therapeutics (P&T) committees. Clinical Therapeutics. 1993;15(2):433-441.
2. American Society of Health-System Pharmacists (ASHP). Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System. American Journal of Health-System Pharmacy. 2021;78(10):907-918.
3. Tyler LS, Cole SW, May JR, et al. ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System. American Journal of Health-System Pharmacy. 2008;65(13):1272-1283.
4. Rucker TD. The role of the hospital formulary in patient care. Hospital Pharmacy. 1986;21(3):201-206.
5. Quick JD, Rankin JR, Laing RO, et al. Managing Drug Supply: The Selection, Procurement, Distribution, and Use of Pharmaceuticals. World Health Organization; 1997. Chapter 8:179-197.
6. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy. 1990;47(3):533-543.
7. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. British Medical Journal. 1996;312(7023):71-72.
8. Donabedian A. The quality of care: How can it be assessed? Journal of the American Medical Association. 1988;260(12):1743-1748.
9. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. Pharmacoeconomics. 1996;10(6):503-512.
10. Holloway K, Green T. Drug and Therapeutics Committees: A Practical Guide. World Health Organization; 2003.
11. McGhan WF. The hospital formulary as a cost-containment tool. Pharmacoeconomics. 1993;3(1):7-14.
12. Laing R, Waning B, Gray A, Ford N. 25 years of the WHO essential medicines lists: progress and challenges. Bulletin of the World Health Organization. 2003;81(9):689-696.
13. Bapna JS, Tripathi CD, Tukur U. Drug formulary and drug utilization pattern in a tertiary care teaching hospital. Indian Journal of Pharmacology. 1992;24(2):95-98.
14. Walley T. Managing drug formularies in the NHS. British Medical Journal. 2004;329(7468):640-642.
15. Joshi MP, Sugimoto T, Santoso B. Geriatric prescribing in a private tertiary care teaching hospital in India: A pilot study. Indian Journal of Pharmacology. 1997;29(2):68-73.
16. Phadke A, Kakade R, Hazra A, et al. Drug supply and utilization in government medical college hospitals in India. Indian Journal of Pharmacology. 2006;38(5):348-352.
17. Sumeragi SB, Avron J. Principles of educational outreach (academic detailing) to improve clinical decision making. Journal of the American Medical Association. 1990;263(4):549-556.
18. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy. 1990;47(3):533-543.
19. World Health Organization. Essential Medicines List. WHO; 2023.
20. American Society of Health-System Pharmacists. Drug Information Handbook. 27th ed. ASHP; 2023.
21. International Pharmaceutical Federation. Guidelines on Hospital Pharmacy Standards. FIP; 2022.